Real Estate Investment Trusts
Search documents
Ventas Declares Quarterly Dividend of $0.48 Per Common Share
Businesswire· 2025-09-18 21:43
Core Viewpoint - Ventas, Inc. has declared a quarterly dividend of $0.48 per common share, reflecting its commitment to returning value to shareholders [1] Company Summary - Ventas, Inc. is a leading S&P 500 real estate investment trust focused on creating exceptional environments for a large and growing aging population [1] - The dividend will be payable in cash on October 16, 2025, to stockholders of record as of the close of business on September 30, 2025 [1]
UDR Declares Quarterly Dividends
Businesswire· 2025-09-18 20:16
DENVER--(BUSINESS WIRE)--UDR, Inc. (NYSE: UDR), a leading multifamily real estate investment trust, today announced that its Board of Directors declared a regular quarterly dividend on its common stock for the third quarter of 2025 in the amount of $0.43 per share, payable in cash on October 31, 2025 to UDR common stock shareholders of record as of October 9, 2025. The October 31, 2025 dividend will be the 212th consecutive quarterly dividend paid by the Company on its common stock. UDR also an. ...
Morning Market Movers: ETNB, APVO, PBM, BEEM See Big Swings
RTTNews· 2025-09-18 11:43
Core Insights - Premarket trading is showing notable activity with significant price movements indicating potential trading opportunities before the market opens [1] Premarket Gainers - 89bio, Inc. (ETNB) increased by 83% to $14.84 [3] - Aptevo Therapeutics Inc. (APVO) rose by 75% to $2.47 [3] - Psyence Biomedical Ltd. (PBM) saw a 29% increase to $4.82 [3] - Beam Global (BEEM) gained 27% reaching $3.23 [3] - MicroAlgo Inc. (MLGO) was up 14% at $13.06 [3] - Akero Therapeutics, Inc. (AKRO) increased by 12% to $47.50 [3] - Hyperion DeFi, Inc. (HYPD) rose by 11% to $13.69 [3] - Sonnet BioTherapeutics Holdings, Inc. (SONN) increased by 11% to $7.85 [3] - FuelCell Energy, Inc. (FCEL) was up 9% at $8.34 [3] - Robo.ai Inc. (AIIO) gained 6% to $2.05 [3] Premarket Losers - Presidio Property Trust, Inc. (SQFT) decreased by 14% to $7.58 [4] - Aeluma, Inc. (ALMU) fell by 10% to $15.18 [4] - FGI Industries Ltd. (FGI) dropped 10% to $7.65 [4] - Lazydays Holdings, Inc. (GORV) was down 9% at $2.26 [4] - StableX Technologies, Inc. (SBLX) decreased by 8% to $5.40 [4] - Artelo Biosciences, Inc. (ARTL) fell by 8% to $4.48 [4] - SciSparc Ltd. (SPRC) decreased by 8% to $4.10 [4] - Cracker Barrel Old Country Store, Inc. (CBRL) was down 7% at $45.75 [4] - Columbus Circle Capital Corp I (BRR) fell by 7% to $9.42 [4] - Visionary Holdings Inc. (GV) decreased by 7% to $2.58 [4]
Plaza Retail REIT declares CAD 0.0233 dividend (TSX:PLZ.UN:CA)
Seeking Alpha· 2025-09-17 17:12
Search fieldEntering text into the input field will update the search result belowEntering text into the input field will update the search result below ...
Residential REITs Face Harsh 2025–'26 Setup As Goldman Sachs Cuts Ratings On Camden, American Homes 4 Rent
Benzinga· 2025-09-17 17:06
Core Viewpoint - Goldman Sachs analyst Julien Blouin expresses caution regarding the residential REIT sector, highlighting challenges for the second half of 2025 and into 2026 due to weaker job growth, slowing migration trends in Sunbelt markets, and rising supply forecasts [1][8][10] Company Summaries - **Camden Property Trust (CPT)**: Downgraded to Sell with a price forecast of $106, down from $118, due to persistent vacancy and supply issues in Sunbelt markets. Expected rent growth for 2026 is only +1.4%, significantly below management's guidance of over 4% [2] - **American Homes 4 Rent (AMH)**: Downgraded to Neutral from Buy, with a price forecast of $37, down from $43. Analysts note a weaker home-selling environment is creating "shadow supply," impacting rent growth through 2026 [3] - **Invitation Homes Inc (INVH)**: Remains the only Buy-rated stock, though price forecast trimmed to $36 from $37. Analysts believe INVH's scale and relative valuation position it better than peers despite moderating rent trends [4] - **Mid-America Apartments Communities Inc (MAA)**: Maintained at Neutral with a price forecast cut to $148 from $163. Updated rent growth models led to the reduction, although lower same-store expenses provided some offset [5] - **Equity Residential (EQR)**: Also rated Neutral, with a slight price forecast reduction to $70 from $72. Key headwinds include softening trends in Washington, D.C., and Boston submarkets [5] - **Essex Property Trust Inc (ESS)**: Rated Neutral, with a price forecast nudged up to $291 from $288. Projected sector-leading rent growth in 2026-2027 is tempered by near-term challenges in Los Angeles submarkets [6] - **UDR Inc. (UDR)**: Maintained at Sell with a price forecast of $37. Analysts cut second-half 2025 lease growth projections due to rising vacancies and slowed rent growth in Washington D.C. and Boston [7] Sector Insights - The residential REIT sector is facing headwinds from persistent supply growth and decelerating migration, particularly in Sunbelt markets, which have absorbed record volumes in recent years [8] - Rent growth expectations for 2026 may be overstated, with subdued performance anticipated in key markets like Houston, Dallas, and Phoenix. Coastal markets, particularly Washington D.C. and Boston, are expected to weaken further [9] - The sector is experiencing one of the weakest job growth environments outside of a recession, limiting demand from significantly outpacing supply [10]
Rithm Capital Agrees to Acquire Paramount For $1.6 Billion
Businesswire· 2025-09-17 11:40
NEW YORK--(BUSINESS WIRE)--Rithm Capital Corp. ("Rithm†or "Rithm Capital†), a global alternative asset manager, announced today that it has entered into a definitive agreement to acquire Paramount Group, Inc. (NYSE: PGRE) ("Paramount†or the "Company†), a vertically-integrated real estate investment trust that owns, operates, manages, and redevelops Class A office properties in New York City and San Francisco, for total cash consideration to Paramount shareholders of approximately $1.6 billion. ...
5 Best Vanguard ETFs to Buy Now
The Motley Fool· 2025-09-17 10:15
Core Insights - Exchange-traded funds (ETFs) have reached $10.3 trillion in U.S. assets, yet many investors still overpay for basic market exposure [2] - Vanguard's unique investor-owned structure allows it to offer lower expense ratios, such as 0.03% for its S&P 500 fund, significantly undercutting competitors [2][5] - The difference in expense ratios can lead to substantial long-term wealth retention, with a 0.03% fee allowing investors to keep 97% of their returns compared to higher fees [3] Vanguard S&P 500 ETF (VOO) - The Vanguard S&P 500 ETF has an expense ratio of 0.03%, equating to a fee of $3 per year on a $10,000 investment, and has delivered a total return of 16% over the past year [5] - This fund is a core holding in portfolio construction, with major tech companies like Apple, Microsoft, and Nvidia making up over 20% of its holdings [6] - The fund offers a 1.16% dividend yield, which can be reinvested to compound returns over time [6] Vanguard Growth ETF (VUG) - The Vanguard Growth ETF has an expense ratio of 0.04% and targets 200 leading growth companies, returning nearly 25% annually over the past three years [8] - The fund includes profitable companies like Amazon and Alphabet, providing growth exposure without high active management fees [9] Vanguard Information Technology ETF (VGT) - The Vanguard Information Technology ETF has an expense ratio of 0.09% and focuses on the tech sector, which has been a major driver of market earnings growth [10] - The fund has delivered annualized returns of nearly 27% over the past three years, with the top 10 holdings representing about 60% of its assets [11] Vanguard Real Estate ETF (VNQ) - The Vanguard Real Estate ETF offers REIT exposure with a 0.13% expense ratio and yields about 3.5%, providing diversification and income generation [12] - Historically, REITs have outperformed during periods when the Federal Reserve cuts rates, making this fund a strategic choice for investors [13] Vanguard Small-Cap Value ETF (VBR) - The Vanguard Small-Cap Value ETF charges an expense ratio of 0.07% and provides access to 835 smaller companies trading at discounted valuations [14] - This segment has historically delivered the highest risk-adjusted returns, offering better risk-reward balance compared to large-cap growth stocks [15]
Advanced Flower Capital Advances Planned Conversion to BDC to Deliver Long-Term Growth and Value Creation
Globenewswire· 2025-09-16 21:15
Core Viewpoint - Advanced Flower Capital Inc. (AFC) is seeking shareholder approval for its conversion from a real estate investment trust (REIT) to a business development company (BDC), with a special meeting scheduled for November 6, 2025 [2][5][10]. Group 1: Shareholder Meeting Details - The special meeting will be conducted virtually on November 6, 2025, at 10:00 a.m. Eastern Time, and shareholders of record as of September 15, 2025, are entitled to vote [3][5]. - Shareholders will receive proxy cards or instructions on how to vote in the coming days [3][7]. Group 2: Proposals for Approval - Two key proposals are being presented for shareholder approval: 1. A new investment advisory agreement compliant with the Investment Company Act of 1940 [6]. 2. The application of a reduced asset coverage ratio as permitted under Section 61(a)(2) of the 1940 Act [6][8]. Group 3: Strategic Rationale - The conversion aims to expand AFC's investment scope beyond real-estate-backed loans, enhancing portfolio diversification and reducing concentration risk [8]. - This strategic shift is expected to better position AFC for long-term sustainable value creation for shareholders [8]. Group 4: Company Background - AFC is a leading commercial mortgage REIT that specializes in originating, structuring, underwriting, and managing senior secured mortgage loans, particularly in the cannabis industry [11]. - The company typically manages loans ranging from $10 million to over $100 million, secured by quality real estate assets and cash flows [11].
Artis Real Estate Investment Trust declares CAD 0.05 dividend (TSX:AX.UN:CA)
Seeking Alpha· 2025-09-16 14:12
Search fieldEntering text into the input field will update the search result belowEntering text into the input field will update the search result below ...
Apple initiated, Hershey upgraded: Wall Street's top analyst calls
Yahoo Finance· 2025-09-16 13:35
Upgrades - Loop Capital upgraded Union Pacific (UNP) to Hold from Sell with a price target of $227, increased from $214, noting shares are down 5% year-to-date and valuation multiples are modestly above five-year lows [2] - BofA upgraded Prologis (PLD) to Buy from Neutral with a price target of $130, up from $118, citing improved lease conversion rates in Q3 compared to Q2 and positive demand-supply dynamics expected through 2026 [3] - Goldman Sachs upgraded Hershey (HSY) to Buy from Sell with a price target of $222, raised from $170, highlighting a compelling risk/reward scenario after multiple guidance reductions [4] - Arete upgraded Baidu (BIDU) to Buy from Sell with a price target of $143, emphasizing the potential of Baidu's Kunlun chip venture to offset challenges in its online advertising business [5] - Citizens JMP upgraded CoreWeave (CRWV) to Outperform from Market Perform with a price target of $180, projecting growth of its GPU-as-a-service business to an estimated $300 billion from $3 billion to $4 billion currently [4] Downgrades - TD Cowen downgraded Warner Bros. Discovery (WBD) to Hold from Buy with an unchanged price target of $14, expressing concerns about the stock's risk/reward after a recent rally [6] - Rothschild & Co Redburn downgraded Live Nation (LYV) to Neutral from Buy with a price target of $170, up from $144, indicating slower margin expansion and reduced earnings upside potential [6] - Stifel downgraded VF Corp. (VFC) to Hold from Buy with a price target of $16, increased from $15, stating that the stock's risk-reward is now balanced after a 12.5% one-month return [6] - JPMorgan downgraded Camp4 Therapeutics (CAMP) to Neutral from Overweight without a price target, noting early-stage challenges in its lead program despite a cash runway into 2027 [6] - JPMorgan downgraded Neumora Therapeutics (NMRA) to Underweight from Neutral without a price target, citing a failed Phase 3 trial for its treatment in major depressive disorder [6]